Metavesco, Inc. has announced that its Regulation A offering is approximately 99% subscribed, with the company's common stock currently trading at approximately double the original offering price of $0.0008 per share. This outcome represents an uncommon achievement for an OTC-listed issuer that did not price its offering at a discount to market value, challenging conventional wisdom about capital formation in over-the-counter markets.
"Raising capital on the OTC without discounting shares is extremely difficult," said Ryan Schadel, CEO of Metavesco. "Most OTC offerings require significant discounts, lack transparency, or fail to reach completion. That reality has existed for a long time." The company received subscription interest from both existing and new shareholders, including several larger retail investors, reflecting continued engagement with Metavesco's strategy and communications.
Schadel highlighted structural challenges facing OTC issuers, noting that while they operate under many of the same regulatory obligations as listed companies, they typically lack equivalent infrastructure to engage investors, communicate consistently, or build long-term participation. "That structural imbalance directly impacts liquidity, price discovery, and cost of capital," he explained. The successful offering positions Metavesco with increased financial flexibility to execute on operating and platform initiatives, allowing deliberate investment in product development, infrastructure, and strategic opportunities.
The company views this experience as informing the development of OTCfi ACCESS, a platform designed to provide OTC issuers with tools to communicate more effectively with shareholders, understand investor engagement, and build durable shareholder bases over time. "MVCO is the case study that proves out the premier platform of the OTCfi ecosystem and illustrates how issuer-focused infrastructure can improve outcomes in the OTC," said Schadel. "The process is repeatable, but most OTC companies lack the infrastructure to support it. OTCfi ACCESS is being built to address that gap."
This development matters because it demonstrates a potential shift in how capital can be raised in OTC markets, which have historically been characterized by discounted offerings and limited transparency. The successful offering without discounting suggests that improved communication and engagement strategies can enhance capital formation efficiency for smaller public companies. For investors, this signals growing sophistication in OTC markets and potentially better alignment between issuers and shareholders. The company emphasized that market outcomes are not guaranteed and depend on various factors including market conditions and issuer-specific execution. This update was initially discussed during a live X Spaces event and can be replayed here. More information about the company is available at metavesco.com and additional details about OTCfi can be found at otcfi.io.
